Psilocybin

Breaking Taboos: Rabbi Leads Research On Psychedelics And Jewish Identity

Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study

Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices

Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study

Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices

TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir

Kelly Slater Talks Psychedelics: Healing Trauma And Unlocking Potential

TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir

Kelly Slater Talks Psychedelics: Healing Trauma And Unlocking Potential

Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia

How To Navigate Difficult Psychedelic Journeys: Research Insights

Psilocybin Recent News

Georgia Lawmakers Take First Steps Toward Psychedelic-Assisted Therapy For Veterans

Georgia lawmakers propose $5M for psychedelic research to treat veterans' PTSD, signaling growing acceptance of alternative mental health therapies.

Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds

A new study shows U.S. healthcare professionals support psychedelic therapies but face significant knowledge gaps, underscoring a need for formal training.

Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids

Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments

Recent patents on novel psychedelic prodrugs show promise in enhancing stability and efficacy, offering new hope for effective mental health treatments.

Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study

Study reveals relaxation, not mystical experiences, as the main factor in the success of psychedelic therapy for treatment-resistant depression.

Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031

Psychedelic mushrooms market to reach $3.3 billion by 2031, due to rising demand, regulatory changes & growing psilocybin acceptance.

UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis

A UK-funded study will explore psilocybin's potential to treat opioid addiction, with a focus on reducing high relapse rates.

Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief

Pro golfers are using psychedelics like psilocybin and DMT to sharpen mental performance, signaling a new trend in sports wellness.

Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health

Joe Rogan and Elon Musk discuss the pharma industry's history of prioritizing profits over health, sparking debate on drug safety and ethics.

Americans Favor Psilocybin For Mental Health Treatment, Study Finds

Most Americans support psilocybin use for mental health and well-being, a new study shows, marking a shift in attitudes toward psychedelics.

Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy

Explore Argentina's golden era of psychedelic therapy (1957-1967), where LSD and psychoanalysis merged for mental health treatments.

Online Mushroom Market Booms: Experts Say Be Very Careful

Websites selling psilocybin are popping up, betting on legalization. But safety and legal concerns persist as the unregulated market grows.

Magic Mushroom Strains: Is There Really A Difference?

New research suggests magic mushroom strains are more alike than different. Focus on cultivation techniques, not strain names, to enhance potency and effects.

Massachusetts Veterans Advocate For Psilocybin Legalization: Will Voters Support Them?

The Optimism Experiment: Psilocybin's Impact On Motivation

Researchers found psilocybin increased optimism in rats, suggesting potential benefits for treating depression symptoms in humans.

Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes

Over 5 million Americans with depression could be eligible for psilocybin-assisted therapy if FDA-approved, signaling vast market potential.

Missouri Allocates $5M For Psilocybin Research To Treat Opioid Addiction

Missouri dedicates $5M from its opioid settlement fund to psilocybin research for treating opioid addiction, seeking expert input on this project.

Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment

Michigan introduces a bill to legalize psychedelic mushrooms for PTSD treatment, allowing adults to possess up to two ounces for personal use

Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder

New study suggests psilocybin may help treat body dysmorphic disorder by rewiring brain connectivity and reducing obsessive thought patterns.

Minnesota Moves Forward With Psilocybin Therapy Plan, Eyes Broader Psychedelic Reforms

Minnesota's Psychedelic Task Force advances a clinical psilocybin therapy program, with broader decriminalization still under consideration.

DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

The DEA increases production quotas for psychedelics like psilocybin and ibogaine, while marijuana quotas remain stable ahead of a possible rescheduling decision.

Psilocybin Found To Be As Effective As Lexapro In Treating Depression, Researchers Say

Psilocybin rivals antidepressants in treating depression while offering long-term well-being benefits, according to a new study.

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.